Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: a retrospective chart review – Kumari S, Manalai P, Leong S, Wooditch A, Malik M, Lawson WB.

Background and Objectives

Opioid use disorders are common, chronic relapsing disorders. Buprenorphine (BUP) is an FDA approved medication in the treatment of opioid use disorders, but patient adherence to this medication remains a challenge. To identify… (Source: SafetyLit)